Stay updated on Nivolumab and Relatlimab in MSS Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and Relatlimab in MSS Colorectal Cancer Clinical Trial page.

Latest updates to the Nivolumab and Relatlimab in MSS Colorectal Cancer Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe page has been updated to a new software/site revision (Revision v3.5.3 instead of v3.5.2). This reflects a version change rather than an update to the clinical study details.SummaryDifference0.1%

- Check15 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedAdded Marinesco-Sjögren syndrome and the Genetic and Rare Diseases Information Center as related resources.SummaryDifference0.2%

- Check44 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check51 days agoChange Detected- The revision tag on the page updated from v3.4.2 to v3.4.3. No visible content changes are indicated.SummaryDifference0.1%

- Check80 days agoChange DetectedAdministrative site updates: the page now lists Revision: v3.4.2 and the older funding-status notice and Revision: v3.4.1 have been removed; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Nivolumab and Relatlimab in MSS Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and Relatlimab in MSS Colorectal Cancer Clinical Trial page.